|
|
my account
log out
|
CAS 1379686-29-9 SR9011 |
| Create: 11/23/2016 |
| Expired Date: | 11/23/2017 |
| Category: | Raw materials [Health&Medical&Pharmaceutical] |
| Message: | Product Name: SR9011 CAS: 1379686-29-9 Molecular Formula: C23H31ClN4O3S Molecular Weight: 479.03524 Purity: 99% Grade: Pharmaceutical Grade Appearance: White Powder SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ. |
![]() | |
| City: | Jinan Shandong[CN]
|
| Location: |
|
| Dec 21 2016 | CAS 593-51-1 Methylamine HCL | 534 | |
| Dec 21 2016 | CAS 83915-83-7 Lisinopril | 563 | |
| Dec 21 2016 | CAS 141922-90-9 Azasetron HCL | 517 | |
| Dec 21 2016 | CAS 15307-79-6 Diclofenac Sodium | 522 | |
| Dec 21 2016 | CAS 104987-11-3 Tacrolimus | 537 | |
| Dec 21 2016 | CAS 68-96-2 17alpha-Hydroxyprogesterone | 552 | |
| Dec 21 2016 | CAS 5534-09-8 Beclometasone Dipropionate | 531 | |
| Dec 18 2016 | SR9011 | 521 | |
| Dec 18 2016 | CAS 118237-47-0 RAD-140 | 559 | |
| Dec 18 2016 | CAS 1202044-20-9 MK-2866 | 533 |
| Copyright © toextrade Inc. All rights reserved. Contact us |